Ranbaxy Nigeria Limited

Ranbaxy Nigeria Limited

Ranbaxy Nigeria Limited is a subsidiary company of Sun Pharmaceuticals Industries Ltd engaged in manufacturing and marketing of pharmaceutical products into the Nigerian market.  Sun pharmaceutical industries are ranked as number One pharmaceutical company in India and 4th Largest Generic Pharma Company of the World.

Ranbaxy Nigeria Limited (a Sun Pharma Company) has production facilities in Nigeria at Magboro Ogun state, fully backed up with Infrastructural facilities geared to manufacture  oral  solid dosages  as well as liquid formulations  ,Ranbaxy Nigeria have invested  on New  green field project and created employment opportunities for local Nigerian. 97% of the people works at Ranbaxy Nigeria are locals.

New Factory Building:

Ranbaxy Nigeria have completed  building a manufacturing facility for  both Oral Solid Dosage  and Oral Liquid Dosage form  at approximate cost of  $29 million within 2.129 hectares of land along Lagos/ Ibadan expressway ,at Magboro, Ibafo, Obafemi /  Owode L.G.A, Ogun State, Nigeria, the facility is built  under the GMP norms of WHO and qualification of specifications as per international standards .  The production capacity is rated for around 42 mio bottles of liquid formulations and 150 – 200 Mill tablets in a year on three shift basis. This completed project is expected to create employment to over 400 Nigerians both skill and non-skill including the young graduates. Currently the Ranbaxy Nigeria Limited has provide employment to over 187 permanent staff.


Gestid Susp, Chericof, Brustan-N, Riconia, Fortwin, Sporidex, Roscilox, Ranferon Iron Tonic, Bacqure, Contiflo OD ,Roliten ,Rosart & Instaclop are popular brands sold in Nigeria.


In Nigeria, we partner with governments, organizations, institutions and parastatals to deliver, first hand, drugs that are relevant to the healthcare needs of the people.

The present total production capacity determined on a single shift basis is close to 1,300,000 bottles a month after installation of the state of the art plant in April 2018..

Approved by NAFDAC with GMP certification.


Ranbaxy Nigeria Ltd (a Sun Pharma Company) having  been operational since 1987;  focus on providing quality service to the market, as a result has a number of exclusive tenders for the supply of Anti Retro Viral drugs from the Federal Ministry of Health, Nigeria, State Ministries of Health, PEPFAR, Global Fund & MSF.

Successful marketing, public awareness and social responsibility activities contribute to the success of Ranbaxy Nigeria Limited- as Sun Pharma Company in Nigeria.





1. Chief B.A Olaogun (Life Bencher) – Chairman

2. Mr. Hanwant Singh Arora – Managing Director

3. Mr. Mahendra Bharadwaj – Vice Chairman

4. Pharm. Samson Yomi Osewa – Director

5. Mr. Hanrin P. Mehta – Director

6. Mr. Mihaly Kaszas – Director




  1. Hanwant Singh Arora – Managing Director
  2. Mrs. Rosanna Iwuala – Supt. Pharmacist
  3. Gunakesh Kumar – Finance Controller
  4. Mathew Phillip – Plant Head
  5. Ademola/Josephine – QA/QC   Manager
  6. Bukola Apata (Mrs.) – Human Resources Manager   
  7. Ekwe.O – OTC Business Head.



Frank K.O dey Esq

52A, Campbell Street




Badru Olaogun & Co

52A, Campbell Street